JP2023527279A5 - - Google Patents

Info

Publication number
JP2023527279A5
JP2023527279A5 JP2022570143A JP2022570143A JP2023527279A5 JP 2023527279 A5 JP2023527279 A5 JP 2023527279A5 JP 2022570143 A JP2022570143 A JP 2022570143A JP 2022570143 A JP2022570143 A JP 2022570143A JP 2023527279 A5 JP2023527279 A5 JP 2023527279A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
cycloalkyl
increase
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022570143A
Other languages
English (en)
Japanese (ja)
Other versions
JP7819118B2 (ja
JP2023527279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033170 external-priority patent/WO2021236779A1/en
Publication of JP2023527279A publication Critical patent/JP2023527279A/ja
Publication of JP2023527279A5 publication Critical patent/JP2023527279A5/ja
Application granted granted Critical
Publication of JP7819118B2 publication Critical patent/JP7819118B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022570143A 2020-05-20 2021-05-19 短鎖デヒドロゲナーゼ活性を調節する組成物及び方法 Active JP7819118B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063027557P 2020-05-20 2020-05-20
US63/027,557 2020-05-20
PCT/US2021/033170 WO2021236779A1 (en) 2020-05-20 2021-05-19 Compositions and methods of modulating short-chain dehydrogenase activity

Publications (3)

Publication Number Publication Date
JP2023527279A JP2023527279A (ja) 2023-06-28
JP2023527279A5 true JP2023527279A5 (https=) 2024-05-27
JP7819118B2 JP7819118B2 (ja) 2026-02-24

Family

ID=76444602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022570143A Active JP7819118B2 (ja) 2020-05-20 2021-05-19 短鎖デヒドロゲナーゼ活性を調節する組成物及び方法

Country Status (19)

Country Link
US (1) US20230192717A1 (https=)
EP (1) EP4153299A1 (https=)
JP (1) JP7819118B2 (https=)
KR (1) KR20230053551A (https=)
CN (1) CN116507626A (https=)
AR (1) AR122137A1 (https=)
AU (1) AU2021275122A1 (https=)
BR (1) BR112022023576A2 (https=)
CA (1) CA3183262A1 (https=)
CL (2) CL2022003255A1 (https=)
CO (1) CO2022018365A2 (https=)
CR (1) CR20220654A (https=)
IL (1) IL298043A (https=)
JO (1) JOP20220317A1 (https=)
MX (1) MX2022014637A (https=)
PE (1) PE20230777A1 (https=)
TW (1) TW202208376A (https=)
UY (1) UY39225A (https=)
WO (1) WO2021236779A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
KR102921276B1 (ko) 2018-11-21 2026-02-03 케이스 웨스턴 리저브 유니버시티 단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
CN114861214B (zh) * 2022-07-08 2022-10-14 智控天下(北京)商业管理有限公司 业务数据监控方法、设备、存储介质及装置
CN118027057A (zh) * 2022-11-14 2024-05-14 武汉人福创新药物研发中心有限公司 抑制15-pgdh的化合物及其用途
TW202434211A (zh) * 2023-02-17 2024-09-01 大陸商武漢人福創新藥物研發中心有限公司 亞碸類化合物及其用途
CN121772923A (zh) * 2023-06-28 2026-03-31 埃皮里姆生物股份有限公司 用于治疗与升高的15-pgdh相关的病况的间歇给药方法
WO2025039000A1 (en) * 2023-08-17 2025-02-20 New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special Prevention and treatment of fibrosis through inhibition or upregulation of specific proteins

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US568159A (en) 1896-06-26 1896-09-22 Veneering-machine
US3382248A (en) 1965-11-01 1968-05-07 Upjohn Co 6-amino-4, 5-di(substituted amino)-1, 2-dihydro-1-hydroxy-2-iminopyrimidines
US4910226A (en) 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
LU87308A1 (fr) 1988-08-01 1990-03-13 Oreal Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
US5015629A (en) 1989-06-26 1991-05-14 University Of Southern California Tissue repair
FR2651122B1 (fr) 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
US5480913A (en) 1989-09-27 1996-01-02 Arch Development Corporation Anti-androgen compounds
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
FR2662607B1 (fr) 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
US5411981A (en) 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2677884B1 (fr) 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
FR2678929A1 (fr) 1991-07-11 1993-01-15 Oreal Compositions pour freiner la chute des cheveux et pour induire et stimuler leur croissance a base de derives de 2,4-diamino pyrimidine 3-oxyde, nouveaux derives 2,4-diamino pyrimidine 3-oxyde.
FR2683531B1 (fr) 1991-11-13 1993-12-31 Rhone Poulenc Rorer Sa Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
TW369521B (en) 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
FR2711060B1 (fr) 1993-10-13 1995-11-17 Oreal Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
SE9303444D0 (sv) 1993-10-20 1993-10-20 Kabi Pharmacia Ab New use of prostaglandins
FR2719481B1 (fr) 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
US5516779A (en) 1994-06-08 1996-05-14 Merck & Co., Inc. 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5807895A (en) 1994-11-29 1998-09-15 Schwarz Pharma, Inc. Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
FR2732597B1 (fr) 1995-04-05 1997-05-16 Oreal Utilisation dans une composition en tant qu'activateur et/ou stabilisateur de cyclooxygenase d'au moins un derive de pyrimidine substitue en 6
US5631282A (en) 1995-06-07 1997-05-20 Merck & Co., Inc. Triterpenes
JPH10215356A (ja) 1996-11-27 1998-08-11 Fuji Photo Film Co Ltd 再プリント用写真画像データの保管方法およびシステム
EP1021179B1 (en) 1997-02-04 2004-05-12 Murray A. Johnstone Method of enhancing hair growth
DE69824445T2 (de) 1997-12-12 2005-06-30 University Of Southern California, Los Angeles Zusammensetzungen zur wundheilung
US20020146439A1 (en) 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
WO2001072268A1 (en) 2000-03-31 2001-10-04 Toray Industries, Inc. Hair growth or hair formation controlling agents
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
FR2812190B1 (fr) 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
WO2008110196A1 (en) * 2007-03-09 2008-09-18 High Point Pharmaceuticals, Llc Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
DK2838533T3 (da) 2012-04-16 2017-11-27 Univ Case Western Reserve Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
WO2014081617A1 (en) 2012-11-20 2014-05-30 Merck Sharp & Dohme Corp. Substituted pyridone derivatives as pde10 inhibitors
AU2014342811B2 (en) 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN107921025A (zh) * 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
AU2016248080A1 (en) * 2015-04-14 2017-11-02 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
US20190275014A1 (en) 2016-07-18 2019-09-12 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting cell death
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
WO2018187810A1 (en) 2017-04-07 2018-10-11 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
US20210317132A1 (en) 2017-05-26 2021-10-14 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
KR102921276B1 (ko) * 2018-11-21 2026-02-03 케이스 웨스턴 리저브 유니버시티 단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
JP7027301B2 (ja) 2018-12-25 2022-03-01 アルタカ株式会社 スクリーン印刷用版枠
JP2020134242A (ja) 2019-02-15 2020-08-31 オリンパス株式会社 計測方法、計測装置、およびプログラム

Similar Documents

Publication Publication Date Title
JP2023527279A5 (https=)
JP7660087B2 (ja) 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
CA2862140C (en) Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
JP2005528105A5 (https=)
Henning et al. Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size
US20250134868A1 (en) Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
JP2008517948A5 (https=)
JP2017525757A (ja) 抗増殖性化合物及びその使用方法
CN108012528A (zh) 调控短链脱氢酶活性的组合物和方法
JP2016537328A (ja) 短鎖デヒドロゲナーゼ活性を調節する組成物および方法
CZ20013483A3 (cs) Pouľití sloučenin podle vynálezu pro přípravu farmaceutických přípravků k léčení leukémie
EP3704126B1 (en) Compounds and use thereof in the expansion of stem cells and/or progenitor cells
JP2022119852A5 (https=)
US20100087436A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
JPWO2004100972A1 (ja) 組織破壊を伴う疾患の予防及び/または治療剤
JP2017137323A (ja) 新規抗がん剤
CA3212314A1 (en) Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcoma
JPH04338331A (ja) γ−ラクトン免疫抑制剤
JP2022513590A5 (https=)
JP5424291B2 (ja) 骨髄細胞の動員剤および動員方法
US20240018129A1 (en) Compounds as pu. 1 inhibitors
HK40105245A (zh) 用於治疗肉瘤的取代的3,6-二氢-2h-1,3,4-恶二嗪-2-酮
JP2024539156A5 (https=)
UA86774C2 (uk) Діарильні і арилгетероарильні похідні сечовини як модулятори 5-нт2а-рецептора серотоніну, придатні для профілактики і лікування пов'язаних з ним захворювань